2020
DOI: 10.3390/v12040384
|View full text |Cite
|
Sign up to set email alerts
|

The Viral Macrodomain Counters Host Antiviral ADP-Ribosylation

Abstract: Macrodomains, enzymes that remove ADP-ribose from proteins, are encoded by several families of RNA viruses and have recently been shown to counter innate immune responses to virus infection. ADP-ribose is covalently attached to target proteins by poly-ADP-ribose polymerases (PARPs), using nicotinamide adenine dinucleotide (NAD+) as a substrate. This modification can have a wide variety of effects on proteins including alteration of enzyme activity, protein–protein interactions, and protein stability. Several P… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

4
104
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
9
1

Relationship

2
8

Authors

Journals

citations
Cited by 92 publications
(108 citation statements)
references
References 56 publications
(96 reference statements)
4
104
0
Order By: Relevance
“…Moreover, the top hits are human protein with a known function: all of them are mono-ADP-ribosyltransferases. This result strongly suggests that the ADP-ribose binding site predicted in the nsp3 protein is functional, as it has been experimentally verified in a number of other viruses, including SARS-CoV (reviewed in [14]). This is the first brick on which I will build my hypothesis: the N terminal part of the SARS-CoV-2 nsp3 protein is constituted of a variable protein-binding domain immediately adjacent to the highly conserved active site of an ADP-ribose (ADPR) processing enzyme.…”
Section: Resultssupporting
confidence: 60%
“…Moreover, the top hits are human protein with a known function: all of them are mono-ADP-ribosyltransferases. This result strongly suggests that the ADP-ribose binding site predicted in the nsp3 protein is functional, as it has been experimentally verified in a number of other viruses, including SARS-CoV (reviewed in [14]). This is the first brick on which I will build my hypothesis: the N terminal part of the SARS-CoV-2 nsp3 protein is constituted of a variable protein-binding domain immediately adjacent to the highly conserved active site of an ADP-ribose (ADPR) processing enzyme.…”
Section: Resultssupporting
confidence: 60%
“…In particular, mutation S1188L is comprised within the SARS-CoV-2 macrodomain (Mac1, residues 1023-1197 of polyprotein 1a), a domain that is present in all coronaviruses. Mac1 binds and removes ADP-ribose from post-translationally modified cellular proteins and this activity counteracts host antiviral ADP-ribosylation [ 42 ]. Remarkably, Mac1 mutation in SARS-CoV does not interfere with virus replication in Vero E6 cell cultures [ 43 ] but mutant virus is highly attenuated in vivo [ 44 – 46 ].…”
Section: Discussionmentioning
confidence: 99%
“…Mutations in the alphavirus and HEV macrodomain also have substantial phenotypic effects on virus replication and pathogenesis (16,(25)(26)(27)(28). As viral macrodomains are clearly important virulence factors, they are considered to be potential targets for anti-viral therapeutics (24).…”
Section: Downloaded Frommentioning
confidence: 99%